Anosmia Clinical Trials

8 recruitingLast updated: July 25, 2026

There are 8 actively recruiting anosmia clinical trials across 6 countries. Studies span Not Applicable. Top locations include Baltimore, Maryland, United States, Copenhagen, Denmark, Holstebro, Central Jutland, Denmark. Updated daily from ClinicalTrials.gov.


Anosmia Trials at a Glance

8 actively recruiting trials for anosmia are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Baltimore, Copenhagen, and Holstebro. Lead sponsors running anosmia studies include Danish Dementia Research Centre, Gaffree & Guinle Universitary Hospital, and Burrell College of Health Sciences.

Browse anosmia trials by phase

Treatments under study

About Anosmia Clinical Trials

Looking for clinical trials for Anosmia? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anosmia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anosmia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial

Olfactory DysfunctionAnosmiaHyposmia
Queen Mary University of London110 enrolled1 locationNCT06600438
Recruiting
Not Applicable

Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults

Olfactory DysfunctionSmell LossAnosmia+1 more
Johns Hopkins University60 enrolled1 locationNCT06733636
Recruiting
Not Applicable

Olfactory Training on Smell Dysfunction Patients in HK

Smell LossSmell DysfunctionOlfaction Disorders+4 more
Pamela Youde Nethersole Eastern Hospital80 enrolled1 locationNCT05364125
Recruiting
Not Applicable

Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19

Anosmia
Burrell College of Health Sciences32 enrolled1 locationNCT06766279
Recruiting
Not Applicable

Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19

SARS-CoV-2 infectionCOVID-19Anosmia+2 more
Université du Québec à Trois-Rivières70 enrolled1 locationNCT05384561
Recruiting

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

Idiopathic AnosmiaIdiopathic HyposmiaIdiopathic Olfactory Dysfunction
Danish Dementia Research Centre100 enrolled2 locationsNCT05740683
Recruiting
Not Applicable

Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19

COVID-19RehabilitationAnosmia+2 more
Gaffree & Guinle Universitary Hospital30 enrolled1 locationNCT06423495
Recruiting

The Nasal Microbiome and Its Importance in Disease

COVID-19Chronic Rhinosinusitis (Diagnosis)Anosmia
University of Aarhus619 enrolled1 locationNCT05061329